2, 2, 2, HU Fu-Liang
Received:
2024-01-04
Revised:
2024-03-26
Online:
2024-04-12
Published:
2024-04-12
Contact:
HU Fu-Liang
CLC Number:
HU Fu-Liang. Research progress on the effect and mechanism of propolis polyphenol in alleviating non-alcoholic fatty liver induced by high fat diet[J]. FOOD SCIENCE.
[1]Giampieri F, Quiles J L, Cianciosi D, et al.Bee Products: An Emblematic Example of Underutilized Sources of Bioactive Compounds[J].Journal of Agricultural and Food Chemistry, 2022, 70(23):6833-6848[2]Anjum S I, Ullah A, Khan K A, et al.Composition and functional properties of propolis (bee glue): A review[J].Saudi Journal of Biological Sciences, 2019, 26(7):1695-1703[3]Kasote D, Bankova V, Viljoen A M.Propolis: chemical diversity and challenges in quality control[J].Phytochemistry Reviews, 2022, 21(6):1887-1911[4]葛怡青, 汪浅, 仝涛.蜂胶功能成分及生物活性研究进展[J].食品安全质量检测学报, 2022, 13(04):1027-1035[5] 国家药典委员会.中华人民共和国药典[M]. 北京: 中国医药科技出版社, 2020.[6]Belmehdia O, El Menyiy N, Bouyahya A, et al.Recent Advances in the Chemical Composition and Biological Activities of Propolis[J].Food Reviews International, 2023, 39(9):6078-6128[7] Feng G, Valenti L, Wong V W-S, et al.Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease[J].Nature Reviews Gastroenterology & Hepatology, 2023, 21:46-56[8]Paik J M, Golabi P, Younossi Y, et al.Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD[J].Hepatology, 2020, 72(5):1605-1616[9]Younossi Z, Anstee Q M, Marietti M, et al.Global burden of NAFLD and NASH: trends,predictions,risk factors and prevention[J].Nature Reviews Gastroenterology & Hepatology, 2018, 15(1):11-20[10]Parthasarathy G, Revelo X, Malhi H.Pathogenesis of Nonalcoholic Steatohepatitis: An Overview[J].Hepatology Communications, 2020, 4(4):478-492[11] Xu X H, Poulsen K L, Wu L J, et al.Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)[J].Signal Transduction and Targeted Therapy, 2022, 7(1):287-287[12] Younossi Z M, Zelber-Sagi S, Henry L, et al.Lifestyle interventions in nonalcoholic fatty liver disease[J].Nature Reviews Gastroenterology & Hepatology, 2023, 20(11):708-722[13]Mitra S, Tareq A, Das R, et al.Polyphenols: A first evidence in the synergism and bioactivities[J].Food Reviews International, 2023, 39(7):4419-4441[14]Nikbaf-Shandiz M, Tutunchi H, Khoshbaten M, et al.Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis,lipid profile,liver function,anthropometric indices and meta-inflammation[J].Food Function, 2022, 13(22):11568-11578[15] Liu W, Feng Y, Yu S, et al.The Flavonoid Biosynthesis Network in Plants[J].International Journal of Molecular Sciences, 2021, 22(23):12824-12824[16]孙圣伟, 何健, 刘美娟, 等.紫外可见分光光度法和高效液相色谱法法测定酒神菊属蜂胶和国产蜂胶中黄酮含量对比研究[J].食品安全质量检测学报, 2019, 10(16):5532-5537[17] Rathod N B, Elabed N, Punia S, et al.Recent Developments in Polyphenol Applications on Human Health: A Review with Current Knowledge[J].Plants, 2023, 12(6):1217-1217[18] Rahman M M, Rahaman M S, Islam M R, et al.Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects[J].Molecules, 2022, 27(1):233-233[19]孙圣伟, 何健, 刘美娟, 等.对比福林酚法和高效液相色谱法测定酒神菊属蜂胶和国产蜂胶中酚酸类化合物含量[J].食品安全质量检测学报, 2020, 11(01):269-274[20]王静, 丁海燕.酚酸类化合物抑菌作用研究进展[J].中成药, 2022, 44(06):1906-1111[21]Hung P V.Phenolic Compounds of Cereals and Their Antioxidant Capacity[J].Critical Reviews in Food Science And Nutrition, 2016, 56(1):25-35[22] 蒋侠森.蜂胶的化学成分?抗氧化谱效分析及长白山蜂胶的特性研究[D].杭州: 浙江大学, 2022.[23]Nyberg L M, Yang S J, Chiang K M, et al.The Natural History of Nonalcoholic Fatty Liver Disease[J].Digestive Diseases And Sciences, 2016, 61(5):1226-1233[24]Easl, Easl, Easd.EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease[J].Journal of Hepatology, 2016, 64(6):1388-1402[25]Day C P, James O F W.Steatohepatitis: A tale of two "hits"?[J].Gastroenterology, 1998, 114(4):842-845[26] Deprince A, Haas J T, Staels B.Dysregulated lipid metabolism links NAFLD to cardiovascular disease[J].Molecular Metabolism, 2020, 42:101092-101092[27] Bovi A P D, Marciano F, Mandato C, et al.Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review[J].Frontiers in Medicine, 2021, 8:595371-595371[28]Koo J H, Han C Y.Signaling Nodes Associated with Endoplasmic Reticulum Stress during NAFLD Progression[J].Biomolecules, 2021, 11(2):242-242[29]Buzzetti E, Pinzani M, Tsochatzis E A.The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)[J].Metabolism-clinical And Experimental, 2016, 65(8):1038-1048[30]Tilg H, Moschen A R.Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis[J].Hepatology, 2010, 52(5):1836-46[31]Nguyen V H, Le M H, Cheung R C, et al.Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD andor MAFLD[J].Clinical Gastroenterology and Hepatology, 2021, 19(10):2172-81[32]Scorletti E, Carr R M M.A new perspective on NAFLD: Focusing on lipid droplets[J].Journal of Hepatology, 2022, 76(4):934-945[33]Feng S, Sun Z, Jia X, et al.Lipophagy: Molecular Mechanisms and Implications in Hepatic Lipid Metabolism[J].Frontiers in Bioscience-landmark, 2023, 28(1):6-6[34] Remmerie A, Scott C L.Macrophages and lipid metabolism[J].Cellular Immunology, 2018, 330:27-42[35]Ipsen D H, Lykkesfeldt J, Tveden-Nyborg P.Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease[J].Cellular And Molecular Life Sciences, 2018, 75(18):3313-3327[36]Alves-Bezerra M, Cohen D E.Triglyceride Metabolism in the Liver[J].Compr Physiol, 2018, 8(1):1-8[37]Geng Y N, Faber K N, de Meijer V E, et al.How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?[J].Hepatology International, 2021, 15(1):21-35[38]Donnelly K L, Smith C I, Schwarzenberg S J, et al.Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease[J].Journal of Clinical Investigation, 2005, 115(5):1343-1351[39]Batchuluun B, Pinkosky S L, Steinberg G R.Lipogenesis inhibitors: therapeutic opportunities and challenges[J].Nature Reviews Drug Discovery, 2022, 21(4):283-305[40]Francque S, Szabo G, Abdelmalek M F, et al.Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors[J].Nature Reviews Gastroenterology & Hepatology, 2021, 18(1):24-39[41]Arroyave-Ospina J C, Wu Z M, Geng Y N, et al.Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy[J].Antioxidants-Basel, 2021, 10(2):174-174[42]Cichoz-Lach H, Michalak A.Oxidative stress as a crucial factor in liver diseases[J].World Journal of Gastroenterology, 2014, 20(25):8082-8091[43]Li S, Tan H Y, Wang N, et al.The Role of Oxidative Stress and Antioxidants in Liver Diseases[J].International Journal of Molecular Sciences, 2015, 16(11):26087-26124[44] Chen Z, Tian R F, She Z G, et al.Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease[J].Free Radical Biology And Medicine, 2021, 152:116-141[45]Schieber M, Chandel N S.ROS Function in Redox Signaling and Oxidative Stress[J].Current Biology, 2014, 24(10):R453-R462[46]Ore A, Akinloye O A.Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease[J].Medicina-Lithuania, 2019, 55(2):26-26[47] Zhang Q, Liu J, Duan H X Y, et al.Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress [J].Journal of Advanced Research, 2021, 34:43-63[48]Peiseler M, Schwabe R F, Hampe J, et al.Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits[J].Journal of Hepatology, 2022, 77(4):1136-1160[49]Pierantonelli I, Svegliati-Baroni G.Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH[J].Transplantation, 2019, 103(1):e1-e13[50] Kumar S, Duan Q H, Wu R X, et al.Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis[J].Advanced Drug Delivery Review, 2021, 176:113869-113869[51]Sutti S, Albano E.Adaptive immunity: an emerging player in the progression of NAFLD[J].Nature Reviews Gastroenterology & Hepatology, 2020, 17(2):81-92[52]Barreby E, Chen P, Aouadi M.Macrophage functional diversity in NAFLD - more than inflammation[J].Nature Reviews Endocrinology, 2022, 18(8):461-472[53]Zhang Q, Jin Y, Xin X, et al.A high-trans fat,high-carbohydrate,high-cholesterol,high-cholate diet-induced nonalcoholic steatohepatitis mouse model and its hepatic immune response[J].Nutrition & Metabolism, 2023, 20(1):28-28[54]Gramignoli R, Ranade A R, Venkataramanan R, et al.Effects of Pro-Inflammatory Cytokines on Hepatic Metabolism in Primary Human Hepatocytes[J].International Journal of Molecular Sciences, 2022, 23(23):14880-14880[55] Liu T, Zhang L Y, Joo D, et al.NF-κB signaling in inflammation[J].Signal Transduction And Targeted Therapy, 2017, 2:17023-17023[56] Zhao W X, Yan Y X, Xiao Z X, et al.Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-KB signaling pathways[J].Biomedicine & Pharmacotherapy, 2021, 141:111874-111874[57]Raza S, Rajak S, Upadhyay A, et al.Current treatment paradigms and emerging therapies for NAFLDNASH[J].Frontiers in Bioscience-landmark, 2021, 26(2):206-237[58]Han H, Jiang Y, Wang M Y, et al.Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis[J].Critical Reviews in Food Science And Nutrition, 2023, 63(12):1689-1706[59]Hsu C L, Schnabl B.The gut-liver axis and gut microbiota in health and liver disease[J].Nature Reviews Microbiology, 2023, 21(11):719-733[60]Hoyles L, Fernández-Real J M, Federici M, et al.Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women[J].Nature Medicine, 2018, 24(7):1070-1080[61] Huang X Q, Chen W F, Yan C S, et al.Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression[J].Biomedicine & Pharmacotherapy, 2019, 118:109258-109258[62]Kolodziejczyk A A, Zheng D P, Shibolet O, et al.The role of the microbiome in NAFLD and NASH[J].Embo Molecular Medicine, 2019, 11(2):e9302-e9302[63]Carpino G, Del Ben M, Pastori D, et al.Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD[J].Hepatology, 2020, 72(2):470-485[64]Jennison E, Byrne C D.The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease[J].Clinical And Molecular Hepatology, 2021, 27(1):22-43[65]Zhou D, Fan J G.Microbial metabolites in non-alcoholic fatty liver disease[J].World Journal of Gastroenterology, 2019, 25(17):2019-2028[66]Canfora E E, Meex R C R, Venema K, et al.Gut microbial metabolites in obesity,NAFLD and T2DM[J].Nature Reviews Endocrinology, 2019, 15(5):261-273[67]Im Y R, Hunter H, Hahn D D, et al.A Systematic Review of Animal Models of NAFLD Finds High-Fat,High-Fructose Diets Most Closely Resemble Human NAFLD[J].Hepatology, 2021, 74(4):1884-1901[68]Koya-Miyata S, Arai N, Mizote A, et al.Propolis Prevents Diet-Induced Hyperlipidemia and Mitigates Weight Gain in Diet-Induced Obesity in Mice[J].Biological & Pharmaceutical Bulletin, 2009, 32(12):2022-2028[69]Orsolic N, Jurcevic I L, Dikic D, et al.Effect of Propolis on Diet-Induced Hyperlipidemia and Atherogenic Indices in Mice[J].Antioxidants, 2019, 8(6):156-156[70]Ichi I, Hori H, Takashima Y, et al.The Beneficial Effect of Propolis on Fat Accumulation and Lipid Metabolism in Rats Fed a High-Fat Diet[J].Journal of Food Science, 2009, 74(5):H127-H31[71]Poznyak A V, Grechko A V, Orekhova V A, et al.Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment[J].Biology-Basel, 2020, 9(3):60-60[72]王子奥, 宋泽和, 张海涵, 等.蜂胶的生物学功能及其在畜禽生产中的应用潜力[J].饲料研究, 2022, 45(20):142-146[73]Yangi B, Ustuner M C, Dincer M, et al.Propolis Protects Endotoxin Induced Acute Lung and Liver Inflammation Through Attenuating Inflammatory Responses and Oxidative Stress[J].J Med Food, 2018, 21(11):1096-1105[74] Kismet K, Ozcan C, Kuru S, et al.Does propolis have any effect on non-alcoholic fatty liver disease?[J].Biomedicine & Pharmacotherapy, 2017, 90:863-871[75] Jin X L, Wang K, Li Q Q, et al.Antioxidant and anti-inflammatory effects of Chinese propolis during palmitic acid-induced lipotoxicity in cultured hepatocytes[J].Journal of Functional Foods, 2017, 34:216-223[76]Zulhendri F, Lesmana R, Tandean S, et al.Recent Update on the Anti-Inflammatory Activities of Propolis[J].Molecules, 2022, 27(23):8473-8473[77] Tutunchi H, Zolrahim F, Nikbaf-Shandiz M, et al.Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial[J].Frontiers in Pharmacology, 2023, 14:1144550-1144550[78]Soleimani D, Rezaie M, Rajabzadeh F, et al.Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial[J].Phytother Res, 2021, 35(3):1669-1679[79]Wang X F, Qi Y, Zheng H.Dietary Polyphenol,Gut Microbiota,and Health Benefits[J].Antioxidants-Basel, 2022, 11(6):1212-1212[80]Wan M L Y, Co V A, El-Nezami H.Dietary polyphenol impact on gut health and microbiota[J].Critical Reviews in Food Science And Nutrition, 2021, 61(4):690-711[81] Cai W, Xu J X, Li G, et al.Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice[J].Food Research International, 2020, 130:108939-108939[82]Zheng Y F, Wu Y Q, Tao L C, et al.Chinese Propolis Prevents Obesity and Metabolism Syndromes Induced by a High Fat Diet and Accompanied by an Altered Gut Microbiota Structure in Mice[J].Nutrients, 2020, 12(4):959-959[83]Pandey P, Khan F, Upadhyay T K, et al.Therapeutic efficacy of caffeic acid phenethyl ester in cancer therapy: An updated review[J].Chemical Biology & Drug Design, 2023, 102(1):201-216[84]Zhong X C, Liu Y M, Gao X X, et al.Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity[J].Acta Pharmacologica Sinica, 2023, 44(1):145-156[85]Natarajan K, Singh S, Burke T R, et al.Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B[J].Proceedings of The National Academy of Sciences of The United States of America, 1996, 93(17):9090-9095[86]Bezerra R M N, Veiga L F, Caetano A C, et al.Caffeic acid phenethyl ester reduces the activation of the nuclear factor κB pathway by high-fat diet-induced obesity in mice[J].Metabolism-clinical And Experimental, 2012, 61(11):1606-1614[87]王凯, 张翠平, 胡福良.巴西绿蜂胶主要生物活性成分的研究进展[J].天然产物研究与开发, 2013, 25(01):140-145[88]Chen Y Q, Wang J, Wang Y B, et al.A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREBCRTC2 transcriptional complex[J].Nature Communications, 2022, 13(1):246-246[89] Ye M H, Fan S H, Li X Y, et al.Four flavonoids from propolis ameliorate free fatty acids-induced non-alcoholic steatohepatitis in HepG2 cells: Involvement of enhanced AMPK activation, mTOR-NF-κBp65 interaction, and PTEN expression[J]. Journal of Functional Foods, 2023, 102. DOI:10.1016/j.jff.2023.105460.[J].Journal of Functional Foods, 2023, 102 :102-102[90]Pai S A, Munshi R P, Panchal F H, et al.Chrysin ameliorates nonalcoholic fatty liver disease in rats[J].Naunyn-schmiedebergs Archives of Pharmacology, 2019, 392(12):1617-1628[91] Liu P, Wu P, Yang B, et al.Kaempferol prevents the progression from simple steatosis to non-alcoholic steatohepatitis by inhibiting the NF-κB pathway in oleic acid-induced HepG2 cells and high-fat diet-induced rats[J].Journal of Functional Foods, 2021, 85:-[92] Zhang X, Deng Y, Xiang J.Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy[J].Drug Design Development And Therapy, 2020, 14:3393-3405 |
[1] | Wei-Ning CHEN Xuan Li Wen-Yue WANG. Review of Progress on Mechanism and Regulation of Enzymatic Browning of Peach and Nectarine [J]. FOOD SCIENCE, 2024, 45(7): 0-0. |
[2] | Zong-Yuan Zhen. Research progress of protein additives in enhancing gel properties of meat products [J]. FOOD SCIENCE, 2024, 45(7): 0-0. |
[3] | BingqianZhou 周 夏吟 马. Research progress on the relationship between colony composition and flavor metabolism of fermented fish products in China [J]. FOOD SCIENCE, 2024, 45(7): 0-0. |
[4] | ZHANG Pengmin, WANG Wenxiu, SUN Jianfeng, CHEN Zhizhou, MA Qianyun, WANG Jie. Antibacterial Effect and Mechanism of Chitosan/Curcumin Composite Photodynamic Coating on Staphylococcus aureus [J]. FOOD SCIENCE, 2024, 45(6): 233-243. |
[5] | NIU Yongwu, QIAO Shan, SUN Yiming, WANG Yuchen, ZHAO Renyong, TIAN Shuangqi. Antibacterial Activity and Mechanism of Rhamnolipids against Bacillus cereus [J]. FOOD SCIENCE, 2024, 45(6): 80-86. |
[6] | ZHANG Jingming, FENG Yangyang, SHI Pingru, KONG Baohua, CAO Chuan’ai, WANG Hui, LIU Qian. Research Progress on Effect of Transglutaminase-Induced Cross-Linking on Gel Properties of Myofibrillar Protein [J]. FOOD SCIENCE, 2024, 45(5): 293-302. |
[7] | LI Yi, CHENG Yongqiang, TANG Ning. Research Progress on the Effect of the Interaction Between Calcium and Iron on Their Absorption in the Intestine [J]. FOOD SCIENCE, 2024, 45(4): 323-335. |
[8] | XIE Huan, HU Ziqing, LIU Xiaoyan, DONG Hao, BAI Weidong, ZENG Xiaofang, WEI Xianling. Progress on the Application of Polyphenol-Polysaccharide Complexes in Food-Grade Pickering Emulsions [J]. FOOD SCIENCE, 2024, 45(3): 247-256. |
[9] | REN Xiangyu, ZHENG Jiawen, TIAN Xiaoxiao, CAO Hongjie, LI Hangting, TANG Yunping, YANG Zuisu. Repairing Effect of Fucoxanthin on Non-alcoholic Fatty Liver Disease in Mice [J]. FOOD SCIENCE, 2024, 45(3): 42-52. |
[10] | NI Dan, JIANG Xinyuan, TANG Yulian, HE Siyi, YANG Yingzhou. Kinetic, Fluorescence Spectroscopy and Molecular Docking Studies of Tyrosinase Inhibition by Ellagic Acid [J]. FOOD SCIENCE, 2024, 45(2): 104-112. |
[11] | ZHANG Shiyu, GAO Meng, WANG Wei, REN Xiaopu, XU Qian, PENG Zengqi. Research Progress on the Inhibitory Mechanism of Plant Polyphenols on the Formation of Heterocyclic Amines in Thermally Processed Meat Products [J]. FOOD SCIENCE, 2023, 44(9): 211-220. |
[12] | OU Kaiyu, PANG Jianlong, ZHANG Yimin, DONG Pengcheng, LUO Xin, MAO Yanwei. A Review of the Antimicrobial Activity of Natural Phenolic Compounds and Their Applications in Meat and Meat Products [J]. FOOD SCIENCE, 2023, 44(9): 358-366. |
[13] | QI Dong, WANG Xiao, LIU Bin, WANG Zhihan, SUN Shiqi. Mechanistic Analysis and Application of Ultrasonic Emulsification of Soy Protein Isolate [J]. FOOD SCIENCE, 2023, 44(9): 32-38. |
[14] | CAO Shuyun, ZHENG Yuxue, CHAI Ziqi, YE Xingqian, TIAN Jinhu. Inhibition Mechanism of Apigenin-8-C-glucoside on Starch Digestive Enzymes [J]. FOOD SCIENCE, 2023, 44(8): 131-136. |
[15] | ZHANG Xiaodi, DONG Ye, ZHANG Yiqi, DAI Zhiyuan. Antifreeze Activity of Surimi By-product Protein Hydrolysate and Its Cryoprotective Effect and Mechanism on Streptococcus thermophilus [J]. FOOD SCIENCE, 2023, 44(7): 39-47. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||